{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T01:59:57Z","timestamp":1774144797236,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Northern Ireland Health and Social Care Research and Development Office","award":["EAT\/5105\/14"],"award-info":[{"award-number":["EAT\/5105\/14"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>In patients with acute hypoxemic respiratory failure (AHRF), the use of lower tidal volume ventilation facilitated by veno-venous extracorporeal C<jats:sc>O<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub> removal (vv-ECCO<jats:sub>2<\/jats:sub>R) does not improve clinical outcomes. The primary objective of this analysis was to evaluate for differences in indices of systemic inflammation and ventilator-induced lung injury between patients treated with lower tidal volume ventilation facilitated by vv-ECCO<jats:sub>2<\/jats:sub>R and standard care. Secondary objectives included an evaluation for heterogeneity of treatment effect.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Substudy of a randomized clinical trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Nine U.K. ICUs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Moderate-to-severe AHRF (Pa<jats:sc>o<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub>: F<jats:sc>io<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub> &lt; 150mmHg [20ka]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTION:<\/jats:title>\n            <jats:p>Plasma samples obtained at baseline and day 3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>The primary outcome was day 3 C-reactive protein (CRP). Clinical outcomes included 90-day mortality and ventilator-free days (VFD) until day 28. Exploratory analyses included an evaluation of plasma indices of lung injury, inflammation, and heterogeneity of treatment effect (HTE). Seventy-nine patients were enrolled, and 69 patients had paired plasma samples taken at baseline and day 3. There was no difference in day 3 plasma CRP (intervention 138.6 [70.4, 189.4] vs. standard care 113.0 [62.7, 233.8] mg\/L; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.72). Between baseline and day 3, there was a greater increase in plasma interleukin-18 in patients that received intervention compared with those that received standard care (\u0394 337.7 [\u2013128.9, 738.9] vs. 6.4 [\u2013457.2, 6.4] pg\/mL <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.05). In patients with high interleukin-18, allocation to intervention was associated with increased VFDs (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.03). Similarly in patients with a hyperinflammatory phenotype, the intervention was independently associated with increased VFDs (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.01) and decreased 90-day mortality (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In patients with moderate-to-severe AHRF, lower tidal volume ventilation, facilitated by vv-ECCO<jats:sub>2<\/jats:sub>R, was not associated with a difference in day 3 plasma CRP, but was associated with an increase in plasma interleukin-18 between baseline and day 3. Baseline plasma interleukin-18 and inflammatory phenotypes may identify subgroups of patients with moderate-to-severe AHRF that benefit from lower tidal volume ventilation facilitated by vv-ECCO<jats:sub>2<\/jats:sub>R.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>TRIAL REGISTRATION:<\/jats:title>\n            <jats:p>NCT02654327<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001246","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T13:23:11Z","timestamp":1743340991000},"page":"e1246","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Plasma Biomarkers to Understand the Biology and Heterogeneity of Treatment Effect in Lower Tidal Volume Ventilation Facilitated by Extracorporeal CO2 Removal in Acute Hypoxemic Respiratory Failure: A Secondary Analysis of the REST Trial"],"prefix":"10.1097","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6201-805X","authenticated-orcid":false,"given":"Andrew J.","family":"Boyle","sequence":"first","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, 97 Lisburn Road, Belfast, United Kingdom."},{"name":"Regional Intensive Care Unit, Royal Victoria Hospital, Grosvenor Road, Belfast, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Reddy","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, 97 Lisburn Road, Belfast, United Kingdom."},{"name":"Regional Intensive Care Unit, Royal Victoria Hospital, Grosvenor Road, Belfast, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Conlon","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, 97 Lisburn Road, Belfast, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Auzinger","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Cleveland Clinic London, London, United Kingdom."},{"name":"King\u2019s College London, Faculty of Life Sciences & Medicine, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Bannard-Smith","sequence":"additional","affiliation":[{"name":"Department of Adult Critical Care, Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom."},{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester, Oxford Road, Manchester, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas A.","family":"Barrett","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."},{"name":"Centre for Human & Applied Physiological Sciences, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King\u2019s College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Camporota","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."},{"name":"Centre for Human & Applied Physiological Sciences, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King\u2019s College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Gillies","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Critical Care and Pain Medicine, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Jackson","sequence":"additional","affiliation":[{"name":"Northern Ireland Clinical Trials Unit, Belfast, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00edona","family":"McDowell","sequence":"additional","affiliation":[{"name":"Northern Ireland Clinical Trials Unit, Belfast, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijesh","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Anaesthetics, Pain Medicine, and Intensive Care, Department of Surgery and Cancer, Imperial College, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin D.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Heartlands Hospital, University Hospitals Birmingham, Birmingham, United Kingdom."},{"name":"Warwick Medical School, University of Warwick, Coventry, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Szakm\u00e1ny","sequence":"additional","affiliation":[{"name":"Critical Care Directorate, Royal Gwent Hospital, Aneurin Bevan University Health Board, Newport, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Tunnicliffe","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg D.","family":"Welters","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"McNamee","sequence":"additional","affiliation":[{"name":"Regional Intensive Care Unit, Royal Victoria Hospital, Grosvenor Road, Belfast, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"McAuley","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, 97 Lisburn Road, Belfast, United Kingdom."},{"name":"Regional Intensive Care Unit, Royal Victoria Hospital, Grosvenor Road, Belfast, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia M.","family":"O\u2019Kane","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, 97 Lisburn Road, Belfast, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"R1-20250327","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries.","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"R2-20250327","first-page":"2526","article-title":"Acute respiratory distress syndrome: The Berlin definition.","volume":"307","year":"2012","journal-title":"JAMA"},{"key":"R3-20250327","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa022450","article-title":"One-year outcomes in survivors of the acute respiratory distress syndrome.","volume":"348","author":"Herridge","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-20250327","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa1011802","article-title":"Functional disability 5 years after acute respiratory distress syndrome.","volume":"364","author":"Herridge","year":"2011","journal-title":"N Engl J Med"},{"key":"R5-20250327","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00134-005-2627-z","article-title":"The concept of \u201cbaby lung\u201d.","volume":"31","author":"Gattinoni","year":"2005","journal-title":"Intensive Care Med"},{"key":"R6-20250327","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.282.1.54","article-title":"Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial.","volume":"281","author":"Ranieri","year":"1999","journal-title":"JAMA"},{"key":"R7-20250327","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/thx.2008.095588","article-title":"Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury.","volume":"63","author":"Calfee","year":"2008","journal-title":"Thorax"},{"key":"R8-20250327","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/cc8230","article-title":"Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: A preventive randomized controlled trial.","volume":"14","author":"Determann","year":"2010","journal-title":"Crit Care"},{"key":"R9-20250327","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jama.2021.13374","article-title":"Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: The REST randomized clinical trial.","volume":"326","author":"McNamee","year":"2021","journal-title":"JAMA"},{"key":"R10-20250327","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-012-2787-6","article-title":"Lower tidal volume strategy (\u22483\u2009ml\/kg) combined with extracorporeal CO2 removal versus \u2018conventional\u2019 protective ventilation (6\u2009ml\/kg) in severe ARDS.","volume":"39","author":"Bein","year":"2013","journal-title":"Intensive Care Med"},{"key":"R11-20250327","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.CCM.0000149854.61192.DC","article-title":"Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.","volume":"33","author":"Parsons","year":"2005","journal-title":"Crit Care Med"},{"key":"R12-20250327","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease.","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"key":"R13-20250327","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1378\/chest.08-2413","article-title":"Plasma C-reactive protein levels are associated with improved outcome in ARDS.","volume":"136","author":"Bajwa","year":"2009","journal-title":"Chest"},{"key":"R14-20250327","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/labinvest.2009.119","article-title":"Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.","volume":"90","author":"McILwain","year":"2010","journal-title":"Lab Invest"},{"key":"R15-20250327","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0267659119830857","article-title":"Mesenchymal stem cells may ameliorate inflammation in an ex vivo model of extracorporeal membrane oxygenation.","volume":"34","author":"von Bahr","year":"2019","journal-title":"Perfusion"},{"key":"R16-20250327","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/MAT.0000000000000544","article-title":"Is extracorporeal CO2 removal really \u201csafe\u201d and \u201cless\u201d invasive? Observation of blood injury and coagulation impairment during ECCO2R.","volume":"63","author":"Kalbhenn","year":"2017","journal-title":"ASAIO J"},{"key":"R17-20250327","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1136\/thoraxjnl-2019-213591","article-title":"Efficacy and safety of lower versus higher CO2 extraction devices to allow ultraprotective ventilation: Secondary analysis of the SUPERNOVA study.","volume":"74","author":"Combes","year":"2019","journal-title":"Thorax"},{"key":"R18-20250327","doi-asserted-by":"crossref","first-page":"L532","DOI":"10.1152\/ajplung.00155.2015","article-title":"Cell-free hemoglobin: A novel mediator of acute lung injury.","volume":"310","author":"Shaver","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R19-20250327","doi-asserted-by":"crossref","first-page":"e0228727","DOI":"10.1371\/journal.pone.0228727","article-title":"Cell-free hemoglobin increases inflammation, lung apoptosis, and microvascular permeability in murine polymicrobial sepsis.","volume":"15","author":"Meegan","year":"2020","journal-title":"PLoS One"},{"key":"R20-20250327","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: Latent class analysis of data from two randomised controlled trials.","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R21-20250327","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.201603-0645OC","article-title":"Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy.","volume":"195","author":"Famous","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-20250327","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: Secondary analysis of a randomised controlled trial.","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R23-20250327","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13054-022-04025-w","article-title":"Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: A secondary analysis of the HARP-2 randomised clinical trial.","volume":"26","author":"Boyle","year":"2022","journal-title":"Crit Care"},{"key":"R24-20250327","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"R25-20250327","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1751143716681035","article-title":"pRotective vEntilation with veno-venouS lung assisT in respiratory failure: A protocol for a multicentre randomised controlled trial of extracorporeal carbon dioxide removal in patients with acute hypoxaemic respiratory failure.","volume":"18","author":"McNamee","year":"2017","journal-title":"J Intensive Care Soc"},{"key":"R26-20250327","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1164\/rccm.201310-1892OC","article-title":"Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury.","volume":"189","author":"Shyamsundar","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-20250327","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"Simvastatin in the acute respiratory distress syndrome.","volume":"371","author":"McAuley","year":"2014","journal-title":"N Engl J Med"},{"key":"R28-20250327","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.athoracsur.2015.11.024","article-title":"Adjust for multiple comparisons? It\u2019s not that simple.","volume":"101","author":"Althouse","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"R29-20250327","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/ALN.0b013e3181b764d2","article-title":"Tidal volume lower than 6\u2009ml\/kg enhances lung protection: Role of extracorporeal carbon dioxide removal.","volume":"111","author":"Terragni","year":"2009","journal-title":"Anesthesiology"},{"key":"R30-20250327","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMsa1410639","article-title":"Driving pressure and survival in the acute respiratory distress syndrome.","volume":"372","author":"Amato","year":"2015","journal-title":"N Engl J Med"},{"key":"R31-20250327","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S2213-2600(19)30369-8","article-title":"Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: A secondary analysis of randomised controlled trials.","volume":"8","author":"Sinha","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R32-20250327","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0000000000003816","article-title":"Association of elevated plasma interleukin-18 level with increased mortality in a clinical trial of statin treatment for acute respiratory distress syndrome.","volume":"47","author":"Rogers","year":"2019","journal-title":"Crit Care Med"},{"key":"R33-20250327","doi-asserted-by":"crossref","first-page":"L165","DOI":"10.1152\/ajplung.00303.2020","article-title":"Inflammasome activation in acute lung injury.","volume":"320","author":"McVey","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R34-20250327","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein.","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front Immunol"},{"key":"R35-20250327","doi-asserted-by":"crossref","first-page":"575","DOI":"10.5301\/ijao.5000617","article-title":"Changes in the levels of beta-thromboglobulin and inflammatory mediators during extracorporeal membrane oxygenation support.","volume":"40","author":"Chung","year":"2017","journal-title":"Int J Artif Organs"},{"key":"R36-20250327","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.3390\/jcm11102782","article-title":"Influence of Advanced Organ Support (ADVOS) on cytokine levels in patients with Acute-on-Chronic Liver Failure (ACLF).","volume":"11","author":"Kaps","year":"2022","journal-title":"J Clin Med"},{"key":"R37-20250327","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13054-016-1570-4","article-title":"The inflammatory response to extracorporeal membrane oxygenation (ECMO): A review of the pathophysiology.","volume":"20","author":"Millar","year":"2016","journal-title":"Crit Care"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T13:24:38Z","timestamp":1743341078000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001246","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}